Dr. Christoph C. Dengler is a former EVP Legal & General Counsel of STADA and German attorney-at-law.
For more than 13 years at STADA, including over 8 years as member of the global Executive Committee, he legally supported the company through its full private-equity lifecycle under Bain Capital and Cinven.
His responsibilities included:
- IPO readiness and dual-track exits
- Global M&A, licensing, co-development and strategic partnerships
- Global compliance and risk management
- Governance and board matters
- Global IP such as patents and trademarks
- Refinancing and disclosure processes
- Complex carve-outs and separations
- Sanctions-sensitive matters
- Litigation and crisis situations
During this period, STADA underwent significant transformation and international growth while operating under private-equity ownership.
Today’s Focus
Today, he advises PE sponsors, portfolio companies and management teams with a particular focus on:
- Exit readiness
- Transaction support (buy and sell-side)
- Complex agreements (e.g. in- and out-licensing, co-development)
- Legal value protection
- Governance and compliance transformation
- Embedded senior legal leadership during critical phases
Pharma and Healthcare Perspective
My background is particularly relevant for pharma and healthcare businesses, where value is often shaped by legal and regulatory complexity, including:
- Licensing and co-development structures
- Supply, distribution and commercialization models
- IP ownership, chain of title and patent strategy
- Compliance in interactions with HCPs, authorities and business partners
- Sanctions, export control and high-risk jurisdictions
- Regulatory and operational dependencies in carve-outs
- Governance and risk structures expected by PE sponsors and buyers
More than 20 years of legal experience in the pharmaceutical sector, including in-house leadership at STADA and Boehringer Ingelheim, with direct exposure to commercial, regulatory, IP, compliance and transaction matters.
Differentiator
Unlike traditional external advisors, his perspective combines legal expertise with operational and investor-focused execution experience from inside a PE-backed global organization.